MENU
OUR PRODUCTS
MOBILE APPS
GENERAL INFO
Help
© 2013-2026 All rights reserved. Tickeron Inc.
KALV
Stock ticker: NASDAQ
PRICE
CHANGE
CAPITALIZATION

KALV stock forecast, quote, news & analysis

KalVista Pharmaceuticals Inc is a pharmaceutical company developing and delivering oral therapies for individuals affected by rare diseases with unmet needs... Show more

Interact to see
Advertisement
A.I.Advisor
published price charts
View AI Trading With up to 88% Returns
View a ticker or compare two or three
Ask AI
VS
Compare
VS
Compare
Interact to see
Advertisement
Related Blogs
NVAX

NVAX vs PDSB: Contrasting Biotech Strategies in Licensing and Clinical Development

NWBO

Northwest Biotherapeutics (NWBO): Breaking Down the $1.00 Target and +560% Upside Potential

SBFM

CRBU vs SBFM: Two Micro-Cap Healthcare Names Under Pressure

LPCN

CRBU vs LPCN: Contrasting Paths for Two Small-Cap Biotech Names

AVBP

Why Is ArriVent BioPharma (AVBP) Stock Down -54.18% Today?

View all blogs related to
#Biotechnology
Interesting Articles

What are Other Mutual Fund Classifications?

Am I Eligible for Social Security Benefits?

What is a Stop Order?

What is the Head-and-Shoulders Bottom (Bullish) Pattern?

What factors contributed to the U.S. Dollar becoming the world's reserve currency?

View all articles
A.I. Advisor
published General Information

General Information

a developer of pharmaceuticals

Industry Biotechnology

Industry
Pharmaceuticals Other
Address
55 Cambridge Parkway
Phone
+1 857 999-0075
Employees
270
Web
https://www.kalvista.com
KALV stock forecast, quote, news & analysis